NCT07052877View on ClinicalTrials.gov

The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
GlioblastomaGlioblastoma Multiforme (GBM)
Interventions
DIAGNOSTIC_TEST

PSMA PET/CT scan

PSMA PET scan will be used to monitor changes in PSMA expression in response to bevacizumab.

Trial Locations (1)

2065

Royal North Shore Hospital, Saint Leonards

All Listed Sponsors
lead

Royal North Shore Hospital

OTHER

NCT07052877 - The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab | Biotech Hunter | Biotech Hunter